In a major development in the pharmaceutical sector, leading Indian drugmakers including Sun Pharma, Dr. Reddy’s Laboratories, Zydus Lifesciences, and Glenmark Pharmaceuticals have begun rolling out generic versions of Semaglutide in India. The move marks a significant push by domestic pharmaceutical companies to tap into the rapidly growing demand for Semaglutide, a widely used drug for managing type 2 diabetes and increasingly popular for weight loss treatment. Industry exp